Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

NYSE:XPOF - New York Stock Exchange, Inc. - US98422X1019 - Common Stock - Currency: USD

8.28  -0.35 (-4.06%)

After market: 8.28 0 (0%)

Fundamental Rating

3

XPOF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 135 industry peers in the Hotels, Restaurants & Leisure industry. While XPOF is still in line with the averages on profitability rating, there are concerns on its financial health. XPOF has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year XPOF has reported negative net income.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

XPOF has a Return On Assets of -16.15%. This is amonst the worse of the industry: XPOF underperforms 91.85% of its industry peers.
The Return On Invested Capital of XPOF (14.51%) is better than 82.22% of its industry peers.
XPOF had an Average Return On Invested Capital over the past 3 years of 10.38%. This is below the industry average of 14.12%.
The last Return On Invested Capital (14.51%) for XPOF is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROIC 14.51%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a better Operating Margin (16.74%) than 71.85% of its industry peers.
With an excellent Gross Margin value of 75.50%, XPOF belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 16.74%
PM (TTM) N/A
GM 75.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

XPOF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, XPOF has more shares outstanding
The number of shares outstanding for XPOF has been increased compared to 5 years ago.
XPOF has a worse debt/assets ratio than last year.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.80. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.80, XPOF is not doing good in the industry: 90.37% of the companies in the same industry are doing better.
XPOF has a debt to FCF ratio of 41.09. This is a negative value and a sign of low solvency as XPOF would need 41.09 years to pay back of all of its debts.
XPOF's Debt to FCF ratio of 41.09 is on the low side compared to the rest of the industry. XPOF is outperformed by 62.22% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Altman-Z -0.8
ROIC/WACC1.32
WACC10.95%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 0.81. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.81, XPOF perfoms like the industry average, outperforming 43.70% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that XPOF may have some problems paying its short term obligations.
The Quick ratio of XPOF (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.75
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

XPOF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.52%.
Looking at the last year, XPOF shows a decrease in Revenue. The Revenue has decreased by -2.99% in the last year.
The Revenue has been growing by 19.93% on average over the past years. This is quite good.
EPS 1Y (TTM)-209.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-3.32%

3.2 Future

XPOF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 211.07% yearly.
Based on estimates for the next years, XPOF will show a small growth in Revenue. The Revenue will grow by 5.97% on average per year.
EPS Next Y857.35%
EPS Next 2Y315.39%
EPS Next 3Y211.07%
EPS Next 5YN/A
Revenue Next Year0.41%
Revenue Next 2Y3.36%
Revenue Next 3Y5.97%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

XPOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
XPOF is valuated cheaply with a Price/Forward Earnings ratio of 5.43.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaper than 97.78% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of XPOF to the average of the S&P500 Index (21.94), we can say XPOF is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.43
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XPOF is on the same level as its industry peers.
XPOF's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 45.8
EV/EBITDA 10.6
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XPOF's earnings are expected to grow with 211.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y315.39%
EPS Next 3Y211.07%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPONENTIAL FITNESS INC-A

NYSE:XPOF (5/21/2025, 8:04:00 PM)

After market: 8.28 0 (0%)

8.28

-0.35 (-4.06%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners80.89%
Inst Owner Change4.19%
Ins Owners4.3%
Ins Owner Change-1.52%
Market Cap401.75M
Analysts78.75
Price Target14.59 (76.21%)
Short Float %13.32%
Short Ratio3.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-8.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-183.83%
Min EPS beat(2)-219.74%
Max EPS beat(2)-147.92%
EPS beat(4)0
Avg EPS beat(4)-148.82%
Min EPS beat(4)-219.74%
Max EPS beat(4)-112.98%
EPS beat(8)0
Avg EPS beat(8)-93.76%
EPS beat(12)0
Avg EPS beat(12)-181.84%
EPS beat(16)0
Avg EPS beat(16)-172.7%
Revenue beat(2)2
Avg Revenue beat(2)0.29%
Min Revenue beat(2)0.01%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)4.31%
Revenue beat(16)14
Avg Revenue beat(16)6.08%
PT rev (1m)0%
PT rev (3m)-26.1%
EPS NQ rev (1m)-12.46%
EPS NQ rev (3m)-43.7%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-51.27%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-6.74%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-6.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.43
P/S 1.26
P/FCF 45.8
P/OCF 27.14
P/B N/A
P/tB N/A
EV/EBITDA 10.6
EPS(TTM)-0.46
EYN/A
EPS(NY)1.53
Fwd EY18.42%
FCF(TTM)0.18
FCFY2.18%
OCF(TTM)0.31
OCFY3.68%
SpS6.55
BVpS-2.23
TBVpS-7.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROCE 18.36%
ROIC 14.51%
ROICexc 15.98%
ROICexgc 148.18%
OM 16.74%
PM (TTM) N/A
GM 75.5%
FCFM 2.76%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Debt/EBITDA 5.07
Cap/Depr 37.13%
Cap/Sales 1.9%
Interest Coverage 1.29
Cash Conversion 21.32%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.75
Altman-Z -0.8
F-Score3
WACC10.95%
ROIC/WACC1.32
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225%
EPS Next Y857.35%
EPS Next 2Y315.39%
EPS Next 3Y211.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-3.32%
Revenue Next Year0.41%
Revenue Next 2Y3.36%
Revenue Next 3Y5.97%
Revenue Next 5YN/A
EBIT growth 1Y-11.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year547.17%
EBIT Next 3Y104.38%
EBIT Next 5YN/A
FCF growth 1Y-79.84%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-75.39%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%